Q2 2008: Esmertec Reports 27.6 Million Jbed Shipments for Mobile and Multimedia Devices and Strong Development of Its ... (GlobeNewswire via Yahoo! Finance)
DUEBENDORF-ZURICH, Switzerland, Sept. 5, 2008 -- Esmertec , a leading provider of software platforms, applications and services to communications device manufacturers and mobile telecom operators, announces that during the second quarter 2008, its mobile and multimedia devices shipments grew by +4.5% and that its mobile subscriber base grew by +46% compared to Q2 2007.
us.rd.yahoo.com

Cameroon: Canada to Build 300 Multimedia Centres in Cameroon (AllAfrica.com)
Government equally signed an agreement with the Korean government for the latter to install a public key infrastructure in the country.
us.rd.yahoo.com

Philip A. Theodore Joins BioReliance Corporation as Vice President, Compliance, Legal and Corporate Development (Business Wire via Yahoo! Finance)
ROCKVILLE, Md.----BioReliance Corporation announced today that Philip A. Theodore has been named Vice President, Compliance, Legal and Corporate Development. BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries ...
us.rd.yahoo.com

China Crescent Enterprises, Inc. VP of Business Development Larry Wu to Present at Small Business Forum in Dongguan, ... (Marketwire via Yahoo! Finance)
China Crescent Enterprises, Inc. today announced Vice President of Business Development Larry Wu will be presenting at the "Summit on the Industrial Transformation of Zhu Jian Delta" on September 23, 2008.
us.rd.yahoo.com

Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration (Business Wire via Yahoo! Finance)
BOTHELL, Wash. & TOKYO----Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. announced today that they have entered into a definitive agreement to co-develop Acucela's lead compound ACU-4429 which is currently in Phase I clinical development for the dry form of age-related macular degeneration in the United States.
us.rd.yahoo.com

Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye (Business Wire via Yahoo! Finance)
BOTHELL, Wash. & TOKYO----Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. today announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension , Otsuka's proprietary compound for the treatment of dry eye which is currently in Phase III clinical development in the United States.
us.rd.yahoo.com

Intel invests in WiMax provider Aicent (Computer Business Review)
Aicent provides data network, messaging, and roaming applications to 100 GSM and CDMA mobile operators, serving approximately 1 billion mobile subscribers. The company, which operates one of the largest multimedia messaging exchanges, competes with Syniverse and VeriSign.
us.rd.yahoo.com

ROTC cadets learn to keep calm during combat water survival test (Journal Gazette & Times-Courier)
Go to our multimedia page to check out some more photos from the training.
us.rd.yahoo.com

Don't Let Your Judgment Get Smitten By Fancy Tech (Investor's Business Daily via Yahoo! News)
That love has propelled him to No. 35 on the 2007 Forbes 400 list, with an estimated worth of $8.7 billion.
us.rd.yahoo.com

AMRI Announces Leadership Changes in Pharmaceutical Development and Manufacturing (Business Wire via Yahoo! Finance)
ALBANY, N.Y.----AMRI announced today that Steven R. Hagen, Ph.D. has been promoted to vice president of pharmaceutical development and manufacturing, reporting to AMRI Chairman, President and CEO Thomas E.
us.rd.yahoo.com